title: Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program.
abstract: The 5485 participants in the Hypertension Detection and Follow-up Program, Stepped-Care group form one of the largest groups to date on which detailed surveillance of long-term antihypertensive therapy and drug side effects has been reported. During a 5-year period, among all hypertensive persons (mild, moderate, and severe combined) who were not taking antihypertensive medications at the beginning of the study and who attended the clinic at least once during the 5-year trial, a total of 9.3% had definite or probable side effects severe enough to cause discontinuation of the drug treatment in question. Less than 1% of active participants required hospitalization for side effects. No death that could be attributed to side effects was detected. Thus, the Hypertension Detection and Follow-up Program data, which have previously demonstrated the beneficial effects of antihypertensive therapy, confirm the relative safety of such therapy.
authors.affiliation: National Institute on Aging, Bethesda, MD 20892.
authors.forename: J D
authors.initials: JD
authors.lastname: Curb
authors.forename: K
authors.initials: K
authors.lastname: Schneider
authors.forename: J O
authors.initials: JO
authors.lastname: Taylor
authors.forename: M
authors.initials: M
authors.lastname: Maxwell
authors.forename: N
authors.initials: N
authors.lastname: Shulman
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002784:Cholesterol / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced
chemical_list: D000959:Antihypertensive Agents; D002784:Cholesterol